Skip to main content
Clinical Trials/CTRI/2019/06/019522
CTRI/2019/06/019522
Not yet recruiting
未知

Comparative evaluation of the clinical efficacy of 3% Satranidazole and 1% Ornidazole in the treatment of chronic periodontitis.

P Bhavana0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K053- Chronic periodontitis
Sponsor
P Bhavana
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
P Bhavana

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients diagnosed with mild to moderate periodontitis according to AAP guidelines, 1999\.
  • 2\.Minimum of 20 teeth in the mouth
  • 3\.Age range of 25\-65 years.
  • 4\.Patients who have not received periodontal treatment for past 6 months to 1 year.

Exclusion Criteria

  • 1\.Patients with uncontrolled systemic diseases.
  • 2\.Patients with aggressive periodontitis.

Outcomes

Primary Outcomes

Not specified

Similar Trials